Cardiology Research and Practice / 2013 / Article / Tab 2 / Research Article
Do Gender and Race/Ethnicity Influence Acute Myocardial Infarction Quality of Care in a Hospital with a Large Hispanic Patient and Provider Representation? Table 2 Selected outcomes in patients admitted with a suspected
and confirmed
Acute Myocardial Infarction according to gender and race ethnicity.
Men Women P valueHispanics Non-Hispanic whites P value
(or M)% (or SD)
(or M)% (or SD)
(or M)% (or SD)
(or M)% (or SD) Suspected AMI
Death 16 7.3 10 4.1 0.129 15 5.2 11 6.3 0.22 Confirmed AMI 212 97.2 175 71.4 <0.001 229 79.8 158 89.8 0.005 Stress testing 10 4.6 54 22 <0.001 43 15.0 21 11.9 0.36 CATH 152 69.7 126 51.4 <0.001 171 59.6 107 60.8 0.79 PCI 80 36.7 54 22 <0.001 82 28.6 52 29.5 0.82 CABG 49 22.5 25 10.2 <0.001 50 17.4 24 13.6 0.28 Confirmed AMI
Death 16 7.5 10 5.7 0.47 15 6.6 11 7 0.87 STEMI 77 36.3 33 18.9 <0.001 59 25.8 51 32.3 0.167 CATH 147 69.3 110 62.9 0.179 154 67.2 103 65.2 0.67 PCI 78 36.8 52 29.7 0.142 78 34.1 52 32.9 0.81 CABG 46 21.7 24 13.7 0.042 47 20.5 23 14.6 0.134 ASA (Hosp) 193 93.7 126 92.1 0.566 185 93.0 136 93.2 0.95 Beta blockers (Hosp) 182 88.3 119 85.6 0.46 175 87.9 126 86.3 0.65 ACEI/ARB (Hosp) 130 63.1 91 65.5 0.65 125 62.8 96 65.8 0.57 Statins/Antilipidemics (Hosp) 154 75.5 104 74.8 0.89 146 73.7 112 77.2 0.46 Clopidogrel (Hosp) 108 52.4 71 51.1 0.81 104 52.3 75 51.4 0.87 ASA (DC) 165 87.3 119 88.1 0.82 165 88.7 119 86.2 0.50 Beta Blockers (DC) 149 78.4 102 75.6 0.54 148 79.1 103 74.6 0.34 ACEI/ARB (DC) 94 50 74 55.2 0.36 95 51.6 73 52.9 0.82 Statins/Antilipidemics (DC) 135 71.4 96 71.1 0.95 135 72.6 96 69.6 0.55 Clopidogrel (DC) 100 53.2 67 49.6 0.53 95 51.1 72 52.6 0.79 Composite medications index 104 75.96 150 76.00 0.96 146 76.2 107 75.73 0.924
AMI: acute myocardial infarction; CATH: cardiac catheterization; PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft; STEMI: ST segment elevation myocardial infarction; ASA: aspirin; Hosp: prescribed on admission; ACEI/ARB: angiotensin converting enzyme inhibitor/Angiotensin receptor blocker; DC: prescribed at discharge.